Ocular Therapeutix, Inc.
US ˙ NasdaqGM ˙ US67576A1007

SecurityOCUL / Ocular Therapeutix, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership243,549 shares
Latest Disclosed Value $ 2,260,134
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 7.17% decrease in ownership of OCUL / Ocular Therapeutix, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 243,549 shares of Ocular Therapeutix, Inc. (US:OCUL) valued at $2,260,135 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 262,371 shares of Ocular Therapeutix, Inc.. This represents a change in shares of -7.17% during the quarter. The current value of the position is $2,009,279 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Ocular Therapeutix EC US67576A1007 243,549 -18,822 -7.17 2,260 17.52 0.0508
2025-05-28 2025-03-31 NP Ocular Therapeutix EC US67576A1007 262,371 0 0.00 1,923 -14.15 0.0461
2025-02-25 2024-12-31 NP Ocular Therapeutix EC US67576A1007 262,371 -45,834 -14.87 2,241 -16.45 0.0489
2024-11-26 2024-09-30 NP Ocular Therapeutix EC US67576A1007 308,205 92,693 43.01 2,681 81.89 0.0507
2024-08-26 2024-06-30 NP Ocular Therapeutix EC US67576A1007 215,512 12,867 6.35 1,474 -20.07 0.0300
2024-05-28 2024-03-31 NP Ocular Therapeutix EC US67576A1007 202,645 57,434 39.55 1,844 185.01 0.0385
2024-02-26 2023-12-31 NP Ocular Therapeutix EC US67576A1007 145,211 12,574 9.48 648 55.53 0.0138
2023-11-28 2023-09-30 NP Ocular Therapeutix EC US67576A1007 132,637 0 0.00 416 -39.18 0.0109
2023-08-25 2023-06-30 NP Ocular Therapeutix EC US67576A1007 132,637 7,510 6.00 684 3.79 0.0162
2023-05-26 2023-03-31 NP Ocular Therapeutix EC US67576A1007 125,127 0 0.00 659 87.75 0.0176
2023-02-24 2022-12-31 NP Ocular Therapeutix EC US67576A1007 125,127 0 0.00 352 -32.37 0.0097
2022-11-25 2022-09-30 NP Ocular Therapeutix EC US67576A1007 125,127 8,612 7.39 519 10.90 0.0149
2022-08-25 2022-06-30 NP Ocular Therapeutix EC US67576A1007 116,515 0 0.00 468 -18.75 0.0129
2022-05-26 2022-03-31 NP Ocular Therapeutix EC US67576A1007 116,515 0 0.00 577 -29.06 0.0134
2022-02-25 2021-12-31 NP Ocular Therapeutix EC US67576A1007 116,515 0 0.00 812 -30.30 0.0176
2021-11-24 2021-09-30 NP Ocular Therapeutix EC US67576A1007 116,515 0 0.00 1,165 -29.48 0.0257
2021-08-26 2021-06-30 NP Ocular Therapeutix EC US67576A1007 116,515 6,178 5.60 1,652 -8.73 0.0354
2021-05-27 2021-03-31 NP Ocular Therapeutix EC US67576A1007 110,337 4,437 4.19 1,811 -17.43 0.0411
2021-02-25 2020-12-31 NP Ocular Therapeutix EC US67576A1007 105,900 7,644 7.78 2,192 193.44 0.0562
2020-11-25 2020-09-30 NP Ocular Therapeutix EC US67576A1007 98,256 10,804 12.35 748 2.61 0.0240
2020-08-27 2020-06-30 NP Ocular Therapeutix EC US67576A1007 87,452 18,007 25.93 728 112.24 0.0238
2020-06-01 2020-03-31 NP Ocular Therapeutix EC US67576A1007 69,445 6,333 10.03 344 37.75 0.0141
2020-02-27 2019-12-31 NP Ocular Therapeutix EC 67576A100 63,112 6,393 11.27 249 44.77 0.0075
2019-11-27 2019-09-30 NP Ocular Therapeutix EC US67576A1007 56,719 56,719 172 0.0057
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.